MedTrace Logo

Stem Cells in Umbilical Blood Infusion for CP

NCT03087110 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2021-01-20

No results posted yet for this study

Summary

This study will investigate the safety of single dose intravenous infusion of cord blood cells which were cryopreserved after the birth of a brother or sister to a child with cerebral palsy.

Conditions

  • Cerebral Palsy

Interventions

BIOLOGICAL

Matched sibling donor cord blood cell infusion

Single dose intravenous infusion of 12/12 HLA matched sibling donor cord blood cells (\>1x10\^7 cells/kg)

Sponsors & Collaborators

  • Royal Children's Hospital

    collaborator OTHER

  • Children's Health Queensland

    collaborator UNKNOWN

  • Monash Health

    collaborator OTHER

  • Sydney Children's Hospitals Network

    collaborator OTHER

  • Cerebral Palsy Alliance

    collaborator OTHER

  • Murdoch Childrens Research Institute

    lead OTHER

Principal Investigators

  • Dinah Reddihough, MBChB, MD · Group leader

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
1 Year
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2019-09-30
Completion
2020-12-31

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03087110 on ClinicalTrials.gov